Longwood Fund
Venture Capital
Active
Boston, United States
61
53M
41
4.36
6
0.33
14
- Stages of investment
- Areas of investment
Summary
In 2010 was created Longwood Founders Fund, which is appeared as VC. The main office of represented VC is situated in the Boston. The fund was located in North America if to be more exact in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TScan Therapeutics, Colorescience, Channel Medsystems. Among the most popular fund investment industries, there are E-Commerce, Life Science. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The current fund was established by Christoph Westphal, Michelle Dipp, Richard Aldrich.
The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017. Speaking about the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Longwood Founders Fund performs on 17 percentage points more the average number of lead investments. The high activity for fund was in 2019.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Longwood Founders Fund, startups are often financed by SV Health Investors, MPM Capital, Delphi Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Bessemer Venture Partners, Novartis Venture Fund. In the next rounds fund is usually obtained by MPM Capital, Vertex Ventures, Cardinal Partners.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 180000000
- Fund raised date
- 2023-05-03
Analytics
- Total investments
- 61
- Lead investments
- 6
- Exits
- 14
- Rounds per year
- 4.36
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (53)
- Health Care (26)
- Therapeutics (22)
- Pharmaceutical (21)
- Life Science (18) Show 25 more
- Investments by region
-
- United States (53)
- United Kingdom (6)
- Germany (1)
- Italy (1)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 236M
- Group Appearance index
- 0.98
- Avg. company exit year
- 7
- Avg. multiplicator
- 4.13
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
DEM BioPharma | 23 Jun 2022 | Biotechnology, Life Science, Pharmaceutical | Early Stage Venture | 70M | United States, Massachusetts, Cambridge |
Progentos Therapeutics | 20 May 2024 | Early Stage Venture | 65M | United States, Massachusetts, Watertown |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.